120 related articles for article (PubMed ID: 29523886)
1. Bortezomib is safe in and stabilizes pulmonary function in patients with allo-HSCT-associated pulmonary CGVHD.
Jain M; Budinger G; Jovanovic B; Dematte J; Duffey S; Mehta J
Bone Marrow Transplant; 2018 Sep; 53(9):1124-1130. PubMed ID: 29523886
[TBL] [Abstract][Full Text] [Related]
2. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia among patients after allogeneic hematopoietic stem cell transplantation and the impact of chronic graft-versus-host disease.
Ljubas Kelecic D; Lelas A; Karas I; Desnica L; Vukic T; Sabol I; Vranesic Bender D; Serventi Seiwerth R; Peric Z; Durakovic N; Vitali Cepo D; Vrhovac R; Nemet D; Pavletic S; Pulanic D; Krznaric Z
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2967-2978. PubMed ID: 32507973
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic graft-versus-host disease with bortezomib.
Pai CC; Chen M; Mirsoian A; Grossenbacher SK; Tellez J; Ames E; Sun K; Jagdeo J; Blazar BR; Murphy WJ; Abedi M
Blood; 2014 Sep; 124(10):1677-88. PubMed ID: 25009225
[TBL] [Abstract][Full Text] [Related]
6. Lung clearance index for early detection of pulmonary complications after allo-HSCT in children.
Uhlving HH; Skov L; Buchvald F; Heilmann C; Grell K; Ifversen M; Green K; Müller K; Nielsen KG
Pediatr Pulmonol; 2019 Jul; 54(7):1029-1038. PubMed ID: 31004401
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.
Chen CT; Liu CY; Yu YB; Liu CJ; Hsiao LT; Gau JP; Chiou TJ; Liu JH; Liu YC
PLoS One; 2017; 12(9):e0185210. PubMed ID: 28934311
[TBL] [Abstract][Full Text] [Related]
8. The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation.
Ditz D; Rabanus R; Schulz C; Wolff D; Holler B; Holler E; Hildebrandt GC
Croat Med J; 2016 Feb; 57(1):16-28. PubMed ID: 26935611
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.
Nakasone H; Sahaf B; Miklos DB
Int J Hematol; 2015 May; 101(5):438-51. PubMed ID: 25812839
[TBL] [Abstract][Full Text] [Related]
10. Multiple Breath Washout Testing to Identify Pulmonary Chronic Graft Versus Host Disease in Children After Hematopoietic Stem Cell Transplantation.
Rayment JH; Sandoval RA; Roden JP; Schultz KR
Transplant Cell Ther; 2022 Jun; 28(6):328.e1-328.e7. PubMed ID: 35139399
[TBL] [Abstract][Full Text] [Related]
11. A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease.
Zallio F; Mazzucco L; Monaco F; Astori MR; Passera R; Drago G; Tamiazzo S; Rapetti M; Dolcino D; Guaschino R; Pini M; Ladetto M
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1664-1670. PubMed ID: 27269196
[TBL] [Abstract][Full Text] [Related]
12. [The clinical characteristics of polyserositis as main presentation of chronic graft-versus-host rejection disease after allogeneic hematopoietic stem cell transplantation].
Wang Q; Li Y; Qiu Z; Xu W; Sun Y; Wang L; Wang M; Liu W; Dong Y; Ou J; Wang W; Liang Z; Wang Q; Cen X; Ren H
Zhonghua Nei Ke Za Zhi; 2014 May; 53(5):394-7. PubMed ID: 25146408
[TBL] [Abstract][Full Text] [Related]
13. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients.
Mueller SM; Haeusermann P; Rovó A; Halter JP; Passweg J; Itin P; Tichelli A
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1574-80. PubMed ID: 23962394
[TBL] [Abstract][Full Text] [Related]
14. Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.
Jang JE; Kim SJ; Cheong JW; Hyun SY; Kim YD; Kim YR; Kim JS; Min YH
Ann Hematol; 2015 Feb; 94(2):275-82. PubMed ID: 25135450
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease.
Herrera AF; Kim HT; Bindra B; Jones KT; Alyea EP; Armand P; Cutler CS; Ho VT; Nikiforow S; Blazar BR; Ritz J; Antin JH; Soiffer RJ; Koreth J
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1737-43. PubMed ID: 25017765
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D
Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
[TBL] [Abstract][Full Text] [Related]
18. The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.
Weissinger EM; Human C; Metzger J; Hambach L; Wolf D; Greinix HT; Dickinson AM; Mullen W; Jonigk D; Kuzmina Z; Kreipe H; Schweier P; Böhm O; Türüchanow I; Ihlenburg-Schwarz D; Raad J; Durban A; Schiemann M; Könecke C; Diedrich H; Holler E; Beutel G; Krauter J; Ganser A; Stadler M
Leukemia; 2017 Mar; 31(3):654-662. PubMed ID: 27677743
[TBL] [Abstract][Full Text] [Related]
19. National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen.
Saillard C; Crocchiolo R; Furst S; El-Cheikh J; Castagna L; Signori A; Oudin C; Faucher C; Lemarie C; Chabannon C; Granata A; Blaise D
Leuk Lymphoma; 2014 May; 55(5):1106-12. PubMed ID: 23822538
[TBL] [Abstract][Full Text] [Related]
20. Genital chronic graft-versus-host disease in females: a cross-sectional study.
Smith Knutsson E; Björk Y; Broman AK; Helström L; Levin Jakobsen AM; Nilsson O; Sundfeldt K; Brune M
Biol Blood Marrow Transplant; 2014 Jun; 20(6):806-11. PubMed ID: 24594123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]